Home All News Stand Down. Stand Down X: Peter Shiff, “We Have Run Out of Road, to... All NewsStand Down. Stand Down X: Peter Shiff, “We Have Run Out of Road, to Kick the Can.” By Editor / Curator - May 19, 2020 Facebook Twitter Google+ Pinterest Linkedin Email RELATED ARTICLESMORE FROM AUTHOR 2024 Watch List Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List. 2024 Watch List Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet. 2024 Watch List GeoVax (GOVX) Launches Vaccine Manufacturing System. All News Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief Science Officer at Immunogen – Join Tharimmune (THAR). Mpox Major Mpox Outbreak in the Democratic Republic of Congo. All News Mpox Infections Rise to Almost Double Last Year’s Numbers. All News Adding Asia Broadband (AABB) to Speculative Watch List. 2024 Watch List GeoVax to Present at World Vaccine Congress, Thursday April 4th. All News Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results. All News Trump’s (DJT) up 48% Today Latest article Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX. Institutional Analyst Newsletter Editor / Curator - May 2, 2024 DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26... Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List. 2024 Watch List Editor / Curator - April 29, 2024 Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever! Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet. 2024 Watch List Editor / Curator - April 27, 2024 CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...